NEW YORK (360Dx) – Rosetta Genomics this week announced an agreement to make the RosettaGX Reveal thyroid miRNA classifier and its other testing services accessible through MediNcrease Health Plans’ regional and national health plans, insurance companies, employers, and other parties. MediNcrease is a national provider network and provider advocacy firm.


Sophia Genetics said that six leading healthcare institutions from across Mexico have adopted Sophia artificial intelligence, which provides clinical genomics solutions for cancer and congenital disorders. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.